首页> 外国专利> High Concentration Antibody formulations, method for reducing the viscosity of a Protein formulation, method of use

High Concentration Antibody formulations, method for reducing the viscosity of a Protein formulation, method of use

机译:高浓度抗体制剂,降低蛋白质制剂粘度的方法,使用方法

摘要

Claim 1: a sterile Liquid formulation which has an absolute viscosity of approximately COP 10 or less comprises (a) a antiesclerostina immunoglobulin a concentration of at least 70 mg / ml; and (b) Calcium acetate at a concentration that is located in the interval d And about 1 mm to 20 mm.Claim 4: a sterile Liquid formulation which has an absolute viscosity of approximately COP 10 or less comprises (a) a antiesclerostina immune globulin at a concentration of approximately 70 mg / ml to approximately 200 mg / ml; and (b) an acetate Salt and / or buffer Acetate at a concentration that is in the range of about 10 mm to approx.And 50 mm acetate, which comprises the immunoglobulin sequences of amino acids: SEC. With no. of ident: 14 and / or sec. With no. of ident: 12; or sec. With no. of ident: 86 and / or sec. With no. of ident: 84; or sec. With no. of ident: 68 and / or sec. With no. of ident: 66; or sec. With no. of ident: 154 and / or sec. With no. of ident: 152; or sec. With no. of ident: 182 and / or sec. With no ident.- 180 sec. With no. of ident: 208 and / or sec. With no. of ident: 207; or sec. With no. of ident: 216 and / or sec. With no. of ident: 214; or sec. With no. of ident: 238 and / or sec. With no. of ident: 236.Claim 8: the formulation of any of claims 1 to 7, where the formulation also includes a polyol such as sucrose, for example, in an amount in the range of about 4% to about 6% w / v P / V.Claim 12: a sterile Liquid formulation which has an absolute viscosity of approximately COP 10 or less comprising: (a) AB 5 at a concentration of at least 70 mg / ml to approximately 200 mg / ml; (b) Calcium acetate at a concentration that is in the range of Approximately 1 mm to 20 mm; and (e) a polyol such as sucrose, e.g.In an amount in the range of about 4% to about 6% w / v P / V.Claim 14: a method of using a therapeutically effective amount of the formulation of any of claims 1 to 9, 12 and 13 for treating a patient suffering from Orthopedic procedures, procedures for Dental implant surgery, Joint Replacement, injert Cosmetic Surgery or Bone, bone and Bone Repair, as Healing of Fractures,Lack of Union Healing, Healing of delayed Unions and facial Reconstruction.
机译:权利要求1:绝对粘度约为COP 10或更低的无菌液体制剂,其包含(a)浓度至少为70 mg / ml的抗僵硬的免疫球蛋白。 (b)乙酸钙,其浓度在d 1到20mm之间。权利要求4:绝对粘度约为COP 10或更低的无菌液体制剂,其包含(a)防蚁锈菌免疫球蛋白。浓度约为70 mg / ml至200 mg / ml; (b)醋酸盐和/或醋酸盐缓冲液,浓度在约10mm至约50mm的醋酸盐之间,其中包含氨基酸的免疫球蛋白序列:SEC。没有。标识号:14和 /或sec。没有。身份证明:12;或秒没有。标识号:86和//或秒。没有。身分:84;或秒没有。标识号:68和//或秒。没有。身份证明:66;或秒没有。标识号:154和 /或秒。没有。识别码:152;或秒没有。标识号:182和 /或sec。无故-180秒没有。标识号:208和//或秒。没有。身份证明:207;或秒没有。标识号:216和//或秒。没有。身份:214;或秒没有。标识号:238和//或秒。没有。 236.权利要求8:权利要求1至7中任一项的制剂,其中所述制剂还包含例如约5%至约6%w / v的量的多元醇如蔗糖。 P./V.Claim 12:绝对粘度约为COP 10或更低的无菌液体制剂,其包含:(a)AB 5浓度为至少70 mg / ml至约200 mg / ml; (b)醋酸钙的浓度范围约为1毫米至20毫米; (e)多元醇如蔗糖,例如其量为约4%至约6%w / v P / v。权利要求14:一种使用治疗有效量的任何形式的制剂的方法13.根据权利要求1至9、12和13所述的方法,其用于治疗骨科手术,牙科植入物手术,关节置换,惰性整容手术或骨,骨和骨修复的患者,作为骨折的愈合,缺乏联合愈合,延迟工会和面部重建。

著录项

  • 公开/公告号AR081912A1

    专利类型

  • 公开/公告日2012-10-31

    原文格式PDF

  • 申请/专利权人 AMGEN INC.;

    申请/专利号AR2011P101652

  • 发明设计人 OSSLUND TIMOTHY D.;

    申请日2011-05-12

  • 分类号A61K39/395;A61P19/00;

  • 国家 AR

  • 入库时间 2022-08-21 17:25:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号